Japan Plans For Enough H1N1 Flu Shots For 25 Million
This article was originally published in PharmAsia News
Executive Summary
Japan's plan to switch in mid-July from producing vaccines against seasonal flu viruses to producing H1N1 vaccines is expected to enable authorities to have enough vaccine on hand to protect 25 million people. The Health Ministry released data that said H1N1 vaccinations could begin in Japan as early as October. The H1N1 supply would be in addition to the stockpile of seasonal flu vaccines, which the ministry said are capable of protecting 40 million people. In January, the government expects to begin producing a vaccine against avian flu. (Click here for more - a subscription may be required
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.